Science Explorer Back to mapMap
Discussion
Researcher · Zhejiang Cancer Hospital · China

Manyi Xu

Manyi Xu publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Research Studies.

ORCID 0000-0002-6937-3652 OpenAlex
World rank
#6,268,188
of 7,710,434 ranked researchers
Rank in China
#871,887
of 978,568
Works
30
Citations
237
Citations per work
7.9
h-index
9
i10-index 9Top 65% in Oncology
Manyi Xu

What does Manyi Xu research?

Manyi Xu's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 21 works · 68.5% of their workMedicine: 21 works · 68.5% of their workOncology: 9 works · 29.2% of their workPulmonary and Respiratory Medicine: 8 works · 25.8% of their workComplementary and alternative medicine: 1 works · 4.5% of their workInfectious Diseases: 1 works · 4.5% of their workSurgery: 1 works · 4.5% of their workEverything else: 6 works · 21.4% of their workLife Sciences: 3 works · 10.1% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 10.1% of their workMolecular Biology: 3 works · 10.1% of their workTHEIR WORKManyi Xu30works
Life Sciences10%Health Sciences68%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2168.5%
  2. Everything else621.4%
    1. Biochemistry, Genetics and Molecular Biology310.1%
  1. 1Oncology29% of their works
  2. 2Pulmonary and Respiratory Medicine26% of their works
  3. 3Molecular Biology10% of their works
  4. 4Surgery4% of their works
  5. 5Infectious Diseases4% of their works
  6. 6Complementary and alternative medicine4% of their works

Research topics

Which keywords describe Manyi Xu's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Tumor Microenvironment, ALK Inhibitors, EGFR Mutations, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Clinical Trials222 topics
  2. Targeted Therapy222 topics
  3. Chemotherapy142 topics
  4. Tumor Microenvironment142 topics
  5. ALK Inhibitors131 topic
  6. EGFR Mutations131 topic
  7. Immune Checkpoint Blockade101 topic
  8. PD-1 and PD-L1101 topic
  9. Genomic Profiles91 topic
  10. Small-Cell Lung Cancer91 topic
  11. Apoptosis72 topics
  12. CT Screening51 topic
  13. Lung Cancer51 topic
  14. Celastrol41 topic
  15. Fibroblast Activation Protein41 topic
  16. Immunosuppression41 topic
  17. Saponins41 topic
  18. Triptolide41 topic
  19. Triterpenoids41 topic
  20. Quinones31 topic
  21. Toxicology31 topic

Where does Manyi Xu work?

Manyi Xu's main affiliation in the publication record is Zhejiang Cancer Hospital, China.

How many publications and citations does Manyi Xu have?

OpenAlex counts 30 works and 237 citations for Manyi Xu, an h-index of 9, ranking #6,268,188 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Manyi Xu. Posts are plain text and can be reported.